- Home
- OCUP vs CVU Comparison
OCUP vs CVU Comparison
Compare OCUP & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- CVU
- Stock Information
- Founded
- OCUP 2018
- CVU 1980
- Country
- OCUP United States
- CVU United States
- Employees
- OCUP N/A
- CVU N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- CVU Military/Government/Technical
- Sector
- OCUP Health Care
- CVU Industrials
- Exchange
- OCUP Nasdaq
- CVU Nasdaq
- Market Cap
- OCUP 53.1M
- CVU 44.2M
- IPO Year
- OCUP N/A
- CVU N/A
- Fundamental
- Price
- OCUP $1.32
- CVU $3.42
- Analyst Decision
- OCUP Strong Buy
- CVU
- Analyst Count
- OCUP 3
- CVU 0
- Target Price
- OCUP $18.67
- CVU N/A
- AVG Volume (30 Days)
- OCUP 86.6K
- CVU 36.2K
- Earning Date
- OCUP 11-11-2024
- CVU 11-12-2024
- Dividend Yield
- OCUP N/A
- CVU N/A
- EPS Growth
- OCUP N/A
- CVU 52.95
- EPS
- OCUP N/A
- CVU 1.33
- Revenue
- OCUP $16,449,000.00
- CVU $83,793,575.00
- Revenue This Year
- OCUP N/A
- CVU N/A
- Revenue Next Year
- OCUP $258.69
- CVU N/A
- P/E Ratio
- OCUP N/A
- CVU $2.56
- Revenue Growth
- OCUP N/A
- CVU N/A
- 52 Week Low
- OCUP $1.15
- CVU $1.30
- 52 Week High
- OCUP $3.53
- CVU $3.54
- Technical
- Relative Strength Index (RSI)
- OCUP 50.56
- CVU 64.71
- Support Level
- OCUP $1.28
- CVU $3.22
- Resistance Level
- OCUP $1.35
- CVU $3.54
- Average True Range (ATR)
- OCUP 0.07
- CVU 0.14
- MACD
- OCUP 0.01
- CVU -0.01
- Stochastic Oscillator
- OCUP 37.50
- CVU 71.25
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.